Pfizer Hit With Suit Claiming Lipitor Caused Diabetes

Law360, New York (October 9, 2013, 12:37 PM EDT) -- Pfizer Inc. was sued Tuesday by a Louisiana woman claiming she developed Type 2 diabetes after taking Pfizer’s blockbuster cholesterol treatment Lipitor for roughly a decade starting in the late 1990s and that the drug giant fraudulently hid Lipitor’s potential link to blood sugar levels until 2012.

In a complaint filed in Louisiana federal court, Gladys Board claimed that Pfizer had not included a warning about increased glucose levels associated with Lipitor until after the U.S. Food and Drug Administration asked it to do so in...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Board v. Pfizer, Inc.


Case Number

3:13-cv-00661

Court

Louisiana Middle

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

James J. Brady

Date Filed

October 8, 2013

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.